Adrianna Gipson

Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea

Hong Sun, John Palcza, Deborah Card et al. · Journal of Clinical Sleep Medicine · 2016 · 76 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors

Lillian L. Siu, Howard A. Burris, Dung T. Le et al. · Cancer Research · 2018 · 64 citations

Pharmacy, Oncology, Pharmacology +17

Characterizing the <scp>PK</scp>/<scp>PD</scp> relationship for inhibition of capsaicin‐induced dermal vasodilatation by <scp>MK</scp>‐3207, an oral calcitonin gene related peptide receptor antagonist

Chi‐Chung Li, Steve Vermeersch, William S. Denney et al. · British Journal of Clinical Pharmacology · 2014 · 24 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy.

Dean F. Bajorin, Elizabeth R. Plimack, Arlene O. Siefker‐Radtke et al. · Journal of Clinical Oncology · 2015 · 11 citations

Medicine, Oncology, Pharmacology +17

KarMMa-7, a Phase 1/2, Dose-Finding and Dose-Expansion Study of Combination Therapies with Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)

Noopur Raje, Jesús G. Berdeja, Paula Rodríguez‐Otero et al. · Blood · 2021 · 10 citations

Medicine, Oncology, Pharmacology +10